DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Liu JF, Gordon M, Veneris J. et al.
Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers.
Gynecol Oncol 2019;
154: 314-322
DOI: 10.1016/j.ygyno.2019.05.021.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.